UCB to acquire Ra Pharmaceuticals in $2.1 billion deal By: MarketWatch October 10, 2019 at 02:28 AM EDT Shareholders of Ra Pharma will receive $48 for each share held, a joint statement by the two companies said Thursday. Read More >> Related Stocks: Ra Pharmaceuticals Inc